Filed: 5/18/2023ACC: 0000950123-23-005544
📋 What this filing means
INTERNATIONAL BIOTECHNOLOGY TRUST PLC filed this quarterly 13F‑HR report disclosing 64 equity positions with a total reported market value of $358.40M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
64
Positions
$358.40M
Total AUM (reported)
11.16M
Total Shares
Allocation by class
COM$288.21M80.4%
SHS$26.35M7.4%
SPONSORED ADR$20.36M5.7%
CL A$7.75M2.2%
SPONSORED ADS$7.12M2.0%
ADR$2.63M0.7%
SHS USD$2.51M0.7%
Portfolio Concentration
Top 3$82.73M23.1%
4–10$96.13M26.8%
11–25$106.45M29.7%
Rest$73.09M20.4%
Top 3 weight
23.1%
Top 10 weight
49.9%
Voting Authority Distribution
Total shares with voting rights: 11.16M
Sole
Full voting authority
11.16M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole64
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings64
Rows:
SEAGEN INC
SOLEShares200.20K
TypeSH
Market value$40.51M
11.30%
Sole
200.20K
Shared
0.00
None
0.00
AMGEN INC COM
SOLEShares91.25K
TypeSH
Market value$22.05M
6.15%
Sole
91.25K
Shared
0.00
None
0.00
INCYTE CORP
SOLEShares279K
TypeSH
Market value$20.16M
5.63%
Sole
279K
Shared
0.00
None
0.00
HARMONY BIOSCIENCES HLDGS
SOLEShares570.50K
TypeSH
Market value$18.62M
5.20%
Sole
570.50K
Shared
0.00
None
0.00
ALKERMES PLC
SOLEShares593K
TypeSH
Market value$16.72M
4.66%
Sole
593K
Shared
0.00
None
0.00
SUPERNUS PHARMS.
SOLEShares423.50K
TypeSH
Market value$15.33M
4.28%
Sole
423.50K
Shared
0.00
None
0.00
INTRA-CELLULAR THERAPIES
SOLEShares257.86K
TypeSH
Market value$13.96M
3.89%
Sole
257.86K
Shared
0.00
None
0.00
ULTRAGENYX PHARM.
SOLEShares264.05K
TypeSH
Market value$10.58M
2.95%
Sole
264.05K
Shared
0.00
None
0.00
EXELIXIS INC
SOLEShares543K
TypeSH
Market value$10.55M
2.94%
Sole
543K
Shared
0.00
None
0.00
VERTEX PHARMACEUTICALS INC
SOLEShares33K
TypeSH
Market value$10.39M
2.90%
Sole
33K
Shared
0.00
None
0.00
UNIQURE NV
SOLEShares478.50K
TypeSH
Market value$9.64M
2.69%
Sole
478.50K
Shared
0.00
None
0.00
ALNYLAM PHARMS.
SOLEShares46.60K
TypeSH
Market value$9.33M
2.60%
Sole
46.60K
Shared
0.00
None
0.00
REGENERON PHARMS.
SOLEShares11.20K
TypeSH
Market value$9.20M
2.57%
Sole
11.20K
Shared
0.00
None
0.00
MIRATI THERAPEUTICS INC
SOLEShares244K
TypeSH
Market value$9.07M
2.53%
Sole
244K
Shared
0.00
None
0.00
SANOFI
SOLEShares143.50K
TypeSH
Market value$7.81M
2.18%
Sole
143.50K
Shared
0.00
None
0.00
VERA THERAPEUTICS
SOLEShares1M
TypeSH
Market value$7.75M
2.16%
Sole
1M
Shared
0.00
None
0.00
CHINOOK THERAPEUTICS
SOLEShares319.99K
TypeSH
Market value$7.41M
2.07%
Sole
319.99K
Shared
0.00
None
0.00
UNITED THERAPEUTICS CORP DEL
SOLEShares28.50K
TypeSH
Market value$6.38M
1.78%
Sole
28.50K
Shared
0.00
None
0.00
AURINIA PHARMACEUTICALS INC
SOLEShares573.53K
TypeSH
Market value$6.28M
1.75%
Sole
573.53K
Shared
0.00
None
0.00
ILLUMINA INC
SOLEShares26.50K
TypeSH
Market value$6.16M
1.72%
Sole
26.50K
Shared
0.00
None
0.00
BIOGEN INC
SOLEShares21.40K
TypeSH
Market value$5.95M
1.66%
Sole
21.40K
Shared
0.00
None
0.00
REVANCE THERAPEUTICS INC
SOLEShares183K
TypeSH
Market value$5.89M
1.64%
Sole
183K
Shared
0.00
None
0.00
BIOMARIN PHARM.
SOLEShares58.66K
TypeSH
Market value$5.70M
1.59%
Sole
58.66K
Shared
0.00
None
0.00
DYNE THERAPEUTICS
SOLEShares433.75K
TypeSH
Market value$4.99M
1.39%
Sole
433.75K
Shared
0.00
None
0.00
BEIGENE ADR
SOLEShares22.70K
TypeSH
Market value$4.89M
1.37%
Sole
22.70K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SEAGEN INCSOLE | COM | 200.20K | SH | $40.51M 11.30% | 200.20K | 0.00 | 0.00 |
AMGEN INC COMSOLE | COM | 91.25K | SH | $22.05M 6.15% | 91.25K | 0.00 | 0.00 |
INCYTE CORPSOLE | COM | 279K | SH | $20.16M 5.63% | 279K | 0.00 | 0.00 |
HARMONY BIOSCIENCES HLDGSSOLE | COM | 570.50K | SH | $18.62M 5.20% | 570.50K | 0.00 | 0.00 |
ALKERMES PLCSOLE | SHS | 593K | SH | $16.72M 4.66% | 593K | 0.00 | 0.00 |
SUPERNUS PHARMS.SOLE | COM | 423.50K | SH | $15.33M 4.28% | 423.50K | 0.00 | 0.00 |
INTRA-CELLULAR THERAPIESSOLE | COM | 257.86K | SH | $13.96M 3.89% | 257.86K | 0.00 | 0.00 |
ULTRAGENYX PHARM.SOLE | COM | 264.05K | SH | $10.58M 2.95% | 264.05K | 0.00 | 0.00 |
EXELIXIS INCSOLE | COM | 543K | SH | $10.55M 2.94% | 543K | 0.00 | 0.00 |
VERTEX PHARMACEUTICALS INCSOLE | COM | 33K | SH | $10.39M 2.90% | 33K | 0.00 | 0.00 |
UNIQURE NVSOLE | SHS | 478.50K | SH | $9.64M 2.69% | 478.50K | 0.00 | 0.00 |
ALNYLAM PHARMS.SOLE | COM | 46.60K | SH | $9.33M 2.60% | 46.60K | 0.00 | 0.00 |
REGENERON PHARMS.SOLE | COM | 11.20K | SH | $9.20M 2.57% | 11.20K | 0.00 | 0.00 |
MIRATI THERAPEUTICS INCSOLE | COM | 244K | SH | $9.07M 2.53% | 244K | 0.00 | 0.00 |
SANOFISOLE | SPONSORED ADR | 143.50K | SH | $7.81M 2.18% | 143.50K | 0.00 | 0.00 |
VERA THERAPEUTICSSOLE | CL A | 1M | SH | $7.75M 2.16% | 1M | 0.00 | 0.00 |
CHINOOK THERAPEUTICSSOLE | COM | 319.99K | SH | $7.41M 2.07% | 319.99K | 0.00 | 0.00 |
UNITED THERAPEUTICS CORP DELSOLE | COM | 28.50K | SH | $6.38M 1.78% | 28.50K | 0.00 | 0.00 |
AURINIA PHARMACEUTICALS INCSOLE | COM | 573.53K | SH | $6.28M 1.75% | 573.53K | 0.00 | 0.00 |
ILLUMINA INCSOLE | COM | 26.50K | SH | $6.16M 1.72% | 26.50K | 0.00 | 0.00 |
BIOGEN INCSOLE | COM | 21.40K | SH | $5.95M 1.66% | 21.40K | 0.00 | 0.00 |
REVANCE THERAPEUTICS INCSOLE | COM | 183K | SH | $5.89M 1.64% | 183K | 0.00 | 0.00 |
BIOMARIN PHARM.SOLE | COM | 58.66K | SH | $5.70M 1.59% | 58.66K | 0.00 | 0.00 |
DYNE THERAPEUTICSSOLE | COM | 433.75K | SH | $4.99M 1.39% | 433.75K | 0.00 | 0.00 |
BEIGENE ADRSOLE | Sponsored ADR | 22.70K | SH | $4.89M 1.37% | 22.70K | 0.00 | 0.00 |
Page 1 of 3